With respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients receive appropriate care. As the calendar shifts to January, the United States finds itself in the midst of a “triple epidemic” in full force, with COVID-19, influenza, … Read more
In a recent article published in Clinical Infectious DiseasesInvestigators estimated the effectiveness of the influenza (VE) vaccine in patients ≥6 months of age seeking outpatient care for acute respiratory illness (ARI) due to influenza A(H3N2) virus between October 2021 and April 2022 in the United States (USA). To study: Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related … Read more
In a recent article published in Clinical Infectious DiseasesInvestigators estimated the effectiveness of the influenza (VE) vaccine in patients ≥6 months of age seeking outpatient care for acute respiratory illness (ARI) due to influenza A(H3N2) virus between October 2021 and April 2022 in the United States (USA). To study: Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related … Read more
In a recent study published in the journal Natural medicineinvestigators presented a whole-transcriptome assessment of changes in blood gene expression that occur in acute COVID-19 (coronavirus disease 2019) and are associated with PASC (post-acute sequelae of COVID-19), commonly known like prolonged COVID-19. PASC comprises a wide range of symptoms such as fatigue, dyspnea, and taste/smell … Read more
People infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show a wide range of clinical variations, from asymptomatic infection to fatal disease. In a recently published study on the bioRxiv* preprint server and an international team of researchers investigated the genetic, immunological, and evolutionary factors that determine the large variability observed in the clinical … Read more
In a recent nature communications In a journal article, investigators determine rates of thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection. These rates were compared to background (expected) rates assessed in the UK general population. To study: Thrombosis and thrombocytopenia following vaccination and SARS-CoV-2 infection in … Read more
All those eligible for the flu vaccine have been urged to come forward as cases rise to levels not seen since before the pandemic. So far this year, uptake of the influenza vaccine in eligible groups is similar to that of recent years, although there is a particular need for preschool-age children, pregnant women, and … Read more
In a recent study published in the lancetResearchers presented comprehensive global estimates of the burden of mortality associated with 33 species or genera of bacterial pathogens that caused 11 major infectious syndromes in 2019 using data and methods from the GBD (Global Burden of Diseases, Injuries, and Risk Factors) Study 2019 and the Global Burden … Read more
In a recent study published in the bioRxiv*preprint server, researchers demonstrated a viral amplification procedure to isolate Omicron subvariants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To study: Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies. Image Credit: Naeblys / Shutterstock In addition, they examined its sensitivity to a panel of … Read more
In a recent study published in the medRxiv*preprint server, researchers demonstrated the presence of the infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in samples from hospital rooms of patients infected with SARS-CoV-2. To study: Detection of infectious SARS-CoV-2 in frozen aerosol samples collected from hospital rooms of COVID-19 patients. Image Credit: creativeneko/Shutterstock Background Although … Read more